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Abstract: Biomimetic binders and catalysts have been generated in order to substitute the biological
pendants in separation techniques and bioanalysis. The two major approaches use either “evolution in
the test tube” of nucleotides for the preparation of aptamers or total chemical synthesis for molecularly
imprinted polymers (MIPs). The reproducible production of aptamers is a clear advantage, whilst
the preparation of MIPs typically leads to a population of polymers with different binding sites.
The realization of binding sites in the total bulk of the MIPs results in a higher binding capacity,
however, on the expense of the accessibility and exchange rate. Furthermore, the readout of
the bound analyte is easier for aptamers since the integration of signal generating labels is well
established. On the other hand, the overall negative charge of the nucleotides makes aptamers
prone to non-specific adsorption of positively charged constituents of the sample and the “biological”
degradation of non-modified aptamers and ionic strength-dependent changes of conformation may
be challenging in some application.
Keywords: biomimetic recognition elements; aptamers; molecularly imprinted polymers; chemical
sensors; aptasensors; in vitro selection; SELEX
1. Introduction
The selective molecular recognition is the very essence of many biological processes; therefore,
the idea to substitute antibodies and enzymes by “biomimetic recognition elements”, either on the
basis of nucleic acids or fully synthetic polymers has fascinated a large community of scientists from
polymer chemistry, biochemistry, organic chemistry, material sciences and bioanalysis. These efforts
involved the rational reconstruction of individual biological units (e.g., bioinspired chemical synthesis
of the active sites of enzymes), as well as the development of universal concepts for generation of
synthetic receptors. Certainly, the second approach seems more attractive for many reasons and,
therefore, this paper aims at presenting probably the two most established concepts in this respect, i.e.,
the molecular imprinting of polymers and the in vitro selection of aptamers for selective recognition
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of proteins. A broad spectrum of “selective sorbents” and later of synthetic polymers with specific
binding sites—so called molecularly imprinted polymers (MIPs)—has been developed based on
early concepts from the 1930s [1,2] and 1940s [3] (Figure 1). This involves polymerizing functional
monomers in the presence of a target compound (analyte for analytical applications) to result in
synthetic polymers that bear the imprint of the target, i.e., the imprinting process generates binding
sites for a given target. The prerequisite of a successful molecular imprinting is the interaction of the
target through covalent (pre-organized approach) [4,5] or non-covalent (self-assembly approach) [6–8]
bonds with the chemically active moieties of the functional monomers in the pre-polymerization
mixture. This arrangement is fixed in the subsequent polymerization of the functional monomers and
reaction with a cross-linker. After polymerization, the template molecules are removed, providing
binding sites that are ideally complementary in size, shape and functionality to the template, thus, the
template preferentially rebinds to these sites.
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Figure 1. Simplistic workflow of molecularly imprinted polymers (MIP)-preparation.
The majority of publications and patents describe MIPs for the recognition of low molecular weight
substances. In spite of the exponentially growing number of publications on MIPs (Figure 2), their
commercial application is still limited to a few examples in separation techniques [9]. The development
of MIPs for proteins had a slow start from 1995 [10], with only a few papers up to 2004, but it exploded
in 2005 [11–14] and covers at present almost ten percent of all publications on MIPs [15]. Protein-MIPs
have great potential in both diagnostic and therapeutic applications. Since the generation of MIPs for
bio-macromolecules is substantially more complex than for small targets this field is still in the phase
of development research.
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Figure 2. Number of publications on protein-imprinted (circles) and all molecularly imprinted
(triangles, right axis) polymers, until the end of 2015 (generated by means of MIPdatabase [16]).
I , t i t t i it t , ll
( t ti l ti of Ligands by EXponential Enrichment), for selection of nucleic acids binding a
target molecule with high affinity a d specificity [17–19], i.e., so-called apt mers. The t m “aptamer”
derived f om the Latin word aptus and the Greek word me os signifying “parts that fit” was introduced
to desc ibe their riginal s lective binding property. Aptamers are primarily sho t, single-stranded
nucleic acids (ssDNA or ssRNA) with a typical length of 20 to 120 nucleotides [20], but peptide aptamers
can b also generated [21–24]. Nucl ic acids can fold into manifold c mplex three-dimensional
structures as a function of their equence and the conditions of their solvents [25–27]. These structural
varieties enable very specific and high-affinity binding to a tar et molecule as a result of a combination
of hydrogen bonds, pi–pi st cking and electrostatic interactions. Aptamers have already been selected
against a multitude of targets, such s small organic molecules [17,28], nucleic acids [29], amino
acids [30,31], antibiotics [32,33], pepti es [34], proteins [19,35], bacteria [36,37], viruses [38], or even
whole living cells [39,40]. The broad selection of su ce sfully appli d target molecules underscores
the grea potential of aptamers as it was possible o develop aptamers with diss ciation constants
(KD values) n the pi om lar to low nanomolar range [27,41], comparable a d s etimes ev n better
than those of mon clonal antibodies. The ge eration of high affine d high specific aptamers requires
well-defined process of several st ps (Figure 3).
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Tuerk and Gold [19] described the SELEX method and its first application to select a RNA aptamer
against the bacteriophage T4 DNA polymerase. This result was only possible by the establishment
of the chemical synthesis of high diversity nucleic acid libraries. Former works by Spiegelman [42]
also isolated RNA ligands against Qβ RNA polymerase but only by evolution experiments. Since the
introduction of SELEX twenty-six years ago, new RNA and DNA aptamers are generated more and
more against different proteins, particularly against those of therapeutic relevance. The number of all
aptamer-related publications is exponentially growing and its current rate (over 1000 publications per
year) is comparable to that of MIP-related publications (Figure 4). This rapid increase is mainly fueled
by the increasing interest in aptamer-based biosensors.
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The measuring process by biomimetic sensors can be divided into two essential steps:
‚ molecular recognit on of the analyte by the aptamer or MIP, which is det rmined by the
corroborative ffect of the composition/sequence and spatial arrangement of the respective
biomimetic el ments.
‚ generation of a measurable signal as result of the interaction of the target-loaded biomimetic
recognition el ment with the transducer.
Both aspects and representative examples of sensors for proteins are presented in this article.
2. Preparation and Performance of MIPs for the Recognition of Proteins
2.1. Building Blocks of MIPs
Proteins are typically made up by the total spectrum of the 20 natural amino acids. Whilst
chemists have a comparable arsenal of building blocks, for the preparation of protein-recognizing
MIPs only one to three different functional monomers are typically used [12]. This is a limitation as
compared with protein-based receptors. Furthermore, the limited conformational stability of proteins
restricts the MIP-synthesis to aqueous conditions where hydrogen bonds are almost inefficient and
hydrophobic interactions are likely to be more significant. Uncharged functional monomers have been
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most widely used for protein MIPs, because electrostatic binding may cause non-specific interactions
with charged constituents of the sample [14].
2.2. Preparation of MIPs for Proteins
2.2.1. Bulk Imprinting of Proteins
The bulk synthesis method, which is well established in synthesis of MIPs for recognition of
low-molecular-weight compounds, is hardly applicable to macromolecules due to their hindered
mobility in the highly reticulated polymeric networks. In the worst scenario the macromolecules
become entrapped in the polymeric material with both their removal and rebinding prohibited.
Nevertheless, “bulk imprinted” hydrogels based on acrylamide or agarose with low density of
cross-linking and large pores have been developed as the precursors of MIPs for the recognition
of proteins [44,45].
2.2.2. Surface Imprinting
The essential prerequisite of macromolecular imprinting to create accessible binding sites
amenable for free target-exchange between the MIP and the sample phase has been fulfilled by
controlling the binding site generation solely at the surface of the polymer, i.e., surface imprinting.
This is generally accomplished by creating the binding sites within highly cross-linked polymer films
(a characteristic of the classical bulk imprinting, which ensures stability of the binding sites). However,
the thickness of this MIP layer is extremely thin, i.e., comparable with the hydrodynamic radius
of the protein so that only partial embedding of the template in the polymer occurs and complete
entrapment is avoided. Such nanofilms will allow then the effective removal and rebinding of the
target analyte. Certainly, there are many ways of realizations of such surface imprinted polymer films
largely determined by the solid support used, orientation of the target, type of polymerization and
functional monomers as well as by geometrical constrictions.
It is important to note that surface imprints are obviously also formed during bulk polymerization,
but generally at low surface densities and large heterogeneities. Therefore, the distinctive feature
of surface imprinting is the utmost control of the imprinting process, in terms of localization, and
reproducible fabrication of homogeneous binding sites most often with large surface densities. In fact,
to maximize the binding capacity of surface imprinted polymers the surface/volume ratio needs to be
increased and therefore the formation of surface imprinted nanoparticles and nanostructures comes as
a natural necessity to fulfill these expectations.
In the simplest approach an ultra-thin layer is formed on the surface of micro or nanoparticles or
directly on the transducer by polymerizing a mixture of the template and monomer (Figure 5A) [46].
On the other hand, suspension, emulsion, or precipitation polymerization, which leads to the
formation of micro- or nanobeads; MIP nanomaterials such as nanoparticles, nanospheres and
MIP nanomaterial composites, have been applied [47–49]. These “Nano-MIPs” offer pronounced
advantages in respect to increased binding capacity and also selective binding of biomacromolecules.
Furthermore, the protein was adsorbed on a planar surface, e.g., of mica or silicon, which is
used to “stamp” a soft polymer layer for the production of protein-imprinted films (micro-contact
imprinting) [50–52].
The homogeneity of the binding sites can be in principle increased if the template is immobilized
in an oriented manner to the solid support prior to polymerization. Additionally, exploitation of a few
but strong interactions at defined sites of the protein molecule with specifically designed monomers
can enhance the imprinting effect. This approach was pioneered by the group of Mosbach. They
used the complex formation between surface-exposed histidine residues of RNase A and a chelator at
the surface of silica beads in the presence of Cu(II). However, the lack of three-dimensional cavities
of a polymer will allow unhindered non-specific binding of other proteins with exposed histidine
residues [10].
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parent protein [61–65]. This approach has several advantages, e.g., the polymerization can be 
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structure. A linear epitope, suitable for imprinting, can only be found at the exposed termini of 
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the surrounding polymer. On the other hand, the imprinting of proteins requires aqueous 
conditions where hydrogen bonds are almost inefficient and hydrophobic interactions are likely to 
be more significant. In addition, the film thickness of surface imprinted layers is smaller than the 
characteristic dimension of the target in order to ensure effective exchange with the sample 
solution. Thus, interaction with the polymer is restricted to a fraction of the macromolecular target 
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Glycoproteins can be immobilized by boronic acids [56,57] enzymes with their inhibitors or
substrates [58,59] and, in general, any reversible receptor can be used as a chor, e.g., aptamers [60].
‚ The preparation of MIPs for the recognition of proteins does not necessarily need the use of the
whole macromolecule as template, but a representative fragment may suffice (epitope approach).
Consequently, imprinting a peptide sequence, which represents a small and exposed part of the
whole protein, was successfully applied for MIPs which recognize the parent protein [61–65].
This approach has several advantages, e.g., the poly erization can be performed in organic
solvents, the cost of the peptide is lower than for the protein, it can be synthesized in a very
pure form and also a well selected peptide sequence may increase selectivity. On the other hand,
the epitopes are typically built up from amino acids located in different sections of the peptide
chain held in spatial proximity by the protein’s tertiary structure. A linear epitope, suitable for
imprinting, can only be found at the exposed termini of the protein. Therefore, larger fragments
of the protein have been also used as the template during polymerization, e.g., the Fab-fragment
for a MIP towards IgG [66].
2.3. Binding Performance of MIPs
The most important parameters characterizing the performance of MIPs are the affinity and
selectivity of target rebinding which determine the dynamic concentration range including the
limit of detection and the cross reactivity. Binding of low molecular weight targets to the MIP
in non-aqueous solvents is dominated by hydrogen bonds [12,15]. Furthermore, the target molecule is
usually completely embedded in the MIP (“bulk imprinting”) resulting in strong interaction with the
surrounding polymer. On the other hand, the imprinting of proteins requires aqueous conditions where
hydrogen bonds are almost inefficient and hydrophobic interactions are likely to be more significant.
In addition, the film thickness of surface imprinted layers is smaller than the characteristic dimension
of the target in order to ensure effective exchange with the sample solution. Thus, interaction with the
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polymer is restricted to a fraction of the macromolecular target and affinity constants for non-covalent
MIPs could hardly reach the sub-nanomolar region [12].
Many attempts have been made to enhance the performance of protein-MIPs by using different
nanostructures on the surface prior to polymer deposition. Among them, the application of
graphene [67] and carbon nanotubes [68] dominate. In addition to their excellent mechanical properties
and electrical conductivity, they provide a large surface for the creation of binding sites.
The imprinting factor (IF), which is defined as the ratio of the signals of the MIP and the
non-imprinted polymer (NIP) after rebinding of the target, reflects the ratio of specific binding of the
MIP to the nonspecific binding at the NIP surface. At saturation concentrations it represents the ratio of
binding capacities to the imprinted and non-imprinted polymer. The imprinting factor is influenced by
the method, which was used to measure the target rebinding to the MIP and NIP. For surface plasmon
resonance (SPR) and quartz crystal microbalance (QCM), the signal can be influenced by structural
changes of the polymer. The frequently used current measurement given by the permeability of the
MIPs to a redox marker—that is inversely proportional with the amount of target bound—reflects, not
only the occupancy of the cavities by the target, but also the formation of “nonspecific” pores, which
are only permeable for the redox marker [69–72]. Therefore, the conditions of template removal are
crucial. The evaluation of the enzymatic activity [59] or of direct electron transfer, applicable however
only for particular targets, is considerably more specific and gives a “functional” imprinting factor.
3. Preparation and Performance of Aptamers for the Recognition of Proteins
3.1. Preparation of Aptamers
Aptamers are primarily generated using the SELEX procedure, an iterative in vitro selection,
in which aptamers are isolated from a random library of at least 1014 different nucleic acids using
a targeted in vitro evolution [73]. In the classical aptamer selection techniques [74–76], the target is
immobilized to a solid surface, for instance by Ni-NTA or streptavidin, for an optimal separation of
non-binding and target binding molecules. It is important to emphasize that for selection of highly
selective aptamers the protein targets need to be very pure and that may require expression of properly
tagged proteins (e.g., His tag) to enable both their purification and controlled immobilization [77,78].
The magnetic particle-based SELEX is one of the core methods, owing in particular to the additional
possibility of automation, which allows the reproducible and parallelized aptamer selection, even
for multiple targets reducing the selection time. Several automated SELEX procedures have been
developed [79–84]. The classical SELEX methodologies were further complemented with different
techniques, such as capillary electrophoresis-based SELEX [85] and whole cell-SELEX [86,87], as well
as their automation [88].
3.2. Binding Performance of Aptamers
Aptamers have various advantages compared to antibodies, which result in a broad field of
applications [89–91]. It is important to emphasize that the aim of the in vitro selection process is solely
to determine the sequence of the aptamers and not their production. Once their sequence established,
aptamers can be inexpensively synthesized and reproduced. This is a major advantage with respect
to MIPs where the imprinting process is directly used for production, i.e., the template is required
all along for the MIP synthesis. Furthermore, the custom synthesis of nucleic acid aptamers enables
their chemical modification for finely tuned physical chemical properties, stabilization and increased
functionality. In particular, the in vivo stability and the half-life of aptamers can be enhanced by
the chemical modification of nucleotides [92] or conjugation of molecules like polyethylene glycol
(PEG) [93]. The integration of reporter groups like fluorescent dyes or biotin at well-defined sites
of the aptamer makes them useful in various sensing applications. Furthermore, the smaller size of
aptamers (<30 kDa) compared to antibodies enables a higher packing density on sensor surfaces and
their in vivo delivery by tissue penetration. The long-term stability of aptamers allows easy storage
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and delivery and aptamers can recover their active conformation after denaturation. Their variety of
structures results in often-higher specificity to a target compared with antibodies. Additionally, the
generation of aptamers can be realized against toxic and non-immunogenic targets because of the pure
in vitro process without the need of animals or in vivo conditions.
Due to these advantages, aptamers are used particularly in the expanding field of aptamer-based
biosensors [94–96], termed aptasensors [97], or in other analytical tools like lateral flow devices for
diagnostic [98], food [75] and environmental [90,99] analysis. Additionally, the therapeutic field offers
further applications of aptamers [100–103]. Aptamers are utilized as imaging [104,105] and therapeutic
agents, in target validation [106] and in regenerative medicine [107]. Furthermore, two special
aspects should be mentioned. The activity of aptamer drugs can be controlled by complementary
sequences (antidotes) because of their ability to interrupt the aptamer-target binding complex [108,109].
Furthermore, the artificial L-ribonucleic acid aptamers, so-called Spiegelmers [110,111], are highly
resistant to degradation by nucleases and have several drug candidates in advanced phases of clinical
research along with emerging diagnostic applications [92]. Despite all their advantages, the general
perception of the aptamers’ performance as compared with that of antibodies is more critical. While
the success of the aptamer selection is by definition probabilistic, the lack of tuning the selection
process by considering the analytical application may also be detrimental for the performance of
the selected aptamers. Ideally, the selection should be performed at the same ionic strength and pH
as of the sample and very importantly counterselections steps should be included during selection
to remove aptamers from the library that bind other constituents of the sample matrix. Aptamer
generation was dramatically increased by the recent development of new SELEX techniques using
alternative nucleic acid libraries of chemically modified nucleobases directly in the in vitro selection
process. Even the main deficiency of not featuring hydrophobic moieties has been addressed by
the implementation of SOMAmers, a new generation of high affinity aptamers for diagnostic and
biomarker discovery [112–114]. Additionally, nucleotides modified by click reaction enable successful
in vitro selection against certain targets, which could not be used successfully in former SELEX
processes [115,116].
4. Catalytically Active MIPs and Aptamers
4.1. Catalytically Active MIPs
Molecularly imprinted polymers have not only been designed for binding of the analyte but also
as enzyme mimics. In analogy with catalytically active antibodies (abzymes), stable analogues of the
postulated transition state (TSA) of the catalyzed reaction are used as the template to mimic the active
center of the enzyme [4,117]. This concept is appropriate for the preparation of hydrolase-like MIPs;
however, the specific activity is several orders of magnitude lower as compared with that of esterase
enzymes [118]. The first example of a MIP catalyst which showed a higher catalytic activity than the
respective catalytic antibodies was realized using phosphate or phosphonate as TSA in the presence of
an amidinium containing monomer and Zn2+ for the catalysis of carbonate hydrolysis [117,119].
In order to mimic redox enzymes, metal ions or metal complexes have been integrated into
the polymer matrix of MIPs. Copper-containing MIPs could mimic the active site of tyrosinase
by oxidizing catechol in the presence of atmospheric oxygen [120] and of nitroreductase in the
electrocatalytic reduction of metronidazole [121]. A mimic of the seleno-enzyme glutathione peroxidase
is based on 3-hydroxypropyl telluride [122] as the catalytic center, which is combined with the
catalytic triad of the enzyme. In addition, redox-active groups of oxidoreductases (e.g., heme [123]
or flavine [124] analogues) have been used in MIPs for the oxidation of 2,4-dichlorophenol [125],
5-hydroxyindole-3-acetamide [126] and homovalinic acid as the catalytic center.
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4.2. Catalytically Active Aptamers: Aptazymes and Riboswitches
Aptamers have occasionally versatile catalytic effects in specific arrangements. Particularly,
aptamers, used as therapeutic agents, or intramers, intracellularly expressed aptamers, have an effect
on different biological pathways by binding to their targets [127].
Furthermore, riboswitches are short regulatory segments of a messenger RNA (mRNA), which
regulate gene expression by binding of metabolites (small molecules) [128,129]. The best known
riboswitches are found in bacteria [130], and also in plant and fungi [131]. The existence of natural
regulatory aptamers (riboswitches) was discovered by the observations of homologies between RNA
sequences in the 51-untranslated region of transcripts and in vitro selected RNA aptamers [132].
The binding of the metabolite by an aptamer sequence induces a modulation of the ribosomal
binding site (RBS) by a structural change of the proximal expression platform, which regulates the
specific gene expression. Nowadays, many types of riboswitches are known, such as Lysine, Glycine,
Purine, S-adenosylhomocysteine (SAH), S-adenosyl methionine (SAM), thiamin pyrophosphate (TPP)
riboswitches, etc. [133].
Additionally, the combination of aptamers and ribozymes (ribonucleic acid enzymes) results in
chimeric molecules, so-called aptazymes, consisting of an aptamer domain and a distant ribozyme
module. These oligonucleotide-regulated ribozymes work like allosteric enzymes in which the catalytic
activity is regulated by the binding of the aptamer target like a small molecule, a protein or another
oligonucleotide [127,134,135]. Many aptazyme-based sample applications have developed in the field
of biotechnology, diagnostics and therapeutics in the recent years. The elucidation of structures of
aptamer-target complexes and ribozymes by NMR [136,137] and crystal [138–140] structure analysis
enables the design of various aptazymes in which the binding of a target by an aptamer is normally
connected with helix stabilization or refolding of the aptamers. Firstly, Breaker and co-workers
developed an aptazyme [141,142] based on the adenosine triphosphate binding (ATP-binding) aptamer
and the hammerhead (HH) ribozyme [143]. In the presence of ATP or adenosine, the cleavage rate of the
ribozyme was decreased 180-fold compared to control reactions with other nucleoside triphosphates
(NTPs) or deoxyadenosine triphosphate (dATP). The flavin mononucleotide (FMN) RNA aptamer
was connected with stem II of HH ribozyme over a short randomized stem. The following in vitro
selections have delivered variants with the potential of activation or inhibition of the HH cleavage
activity in the presence of FMN [144,145]. Furthermore, aptazymes can be used as reporter ribozymes
for screening processes in biosensors. For example, an adenosine diphosphate (ADP) aptamer based
allosteric ribozyme was generated to monitor the pERK2 protein kinase activity in the presence of
different drug-like compounds [146], whereas a protein-dependent ribozyme was utilized for affinity
screening of the HIV-1 reverse transcriptase (RT) to a large library of 2500 compounds [147]. In addition,
further aptazymes are based on a wide range of ribozymes like the hairpin ribozyme [148,149], the
ligase ribozyme [150,151] or the Diels-Alder ribozyme [152,153].
5. Chemical Sensing Schemes
After their sequence established nucleic acid aptamers are produced by routine chemical
synthesis, which offers utmost versatility in tuning their structure for chemical sensing applications.
Thus the recognition sequence can be complemented with various functionalities, such as to
enable straightforward immobilization to sensor transducers or nanoparticles, as well as with
probes/reporters for signal generation, e.g., fluorescent and redox probes [154]. Aptamer-based
protein sensing benefits additionally also from the broad methodological basis of nucleic acid assays,
with many of the methods being inherent to nucleic acids, e.g., molecular beacons, polymerase
chain reactions, etc. Thus, a large number of aptamer-based fluorescent detection methods were
designed involving folding-refolding of aptamer strands [155], strand assembly-disassembly [156,157],
as well as a variety of displacement assays. On the analogy of the fluorescent molecular beacons
electrochemical detection of proteins can be enabled by using redox reporters incorporated in aptamer
strands [158]. In this case, the aptamers are immobilized on an electrode surface and the electron
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transfer between the electrode and the redox active probe is modulated by the protein binding, i.e., the
distance over which the charge transfer occurs is changed by the binding. Without entering deeper
in the plethora of aptamer-based protein sensing schemes [159] the use of nucleic acid amplification
schemes, which are again distinct properties of nucleic acid aptamers, is definitely worth mentioning.
These schemes take advantage of the detection of the specifically bound nucleic acid aptamer strand
or its designed elongations to implement it directly or indirectly as a template for polymerase chain
reaction [160,161], rolling circle amplification [162], proximity ligation assay [163], etc. Thus in terms of
the resourcefulness of sensing schemes aptamers have a clear advantage over MIPs, but this does not
mean that MIPs lack “unique” transduction schemes. MIPs are materials with adjustable dimensions
and properties that were exploited in sensing, e.g., growing photonic protein imprinted polymers by
colloidal templating allows label-free quantitation of target proteins via recording the shift in their stop
band upon protein biding [164]. Similarly, surface imprinted polymer nanofilms enable the label-free
electrochemical sensing of target binding through the modulating effect on the permeability of these
films [165].
In addition to the particular sensing schemes the general approaches that are implemented in other
affinity assays, e.g., in immunosensors and DNA chips, were seamlessly overtaken for these biomimetic
receptors. However, their surface confinement, interfacing with transducers and mechanism of action
show many interesting features and challenges.
At the beginning of the analytical applications of MIPs and aptamers, both analytical reactors in
flow systems [166,167] and lateral flow devices in the test strip format [168,169] have been described.
For the realization of a biomimetic sensor the analyte recognition by the MIP or aptamer should be in
close proximity to the surface of the signal generating transducer. Therefore, the aptamer has to be
immobilized directly at the surface. MIP sensors mostly apply “surface imprinted” layers directly on
the electrode, QCM-crystal or SPR-chip. Most often, the following schemes are applied:
‚ Label-free evaluation of changes of the recognition layer upon binding of the target protein by
QCM and SPR
Both methods are especially appropriate for the detection of macromolecules whilst the
measurement of low-molecular weight substances has low sensitivity. For SPR [46,58] and
QCM [53,54,58,170] the signal reflects overall changes of refractive index or mass of the recognition
layer, which can be induced not only by the target but also by nonspecific adsorption especially by
electrostatic interactions with the negatively charged aptamer skeleton. For MIPs changes of the
polymer layer swelling or shrinking can mask the binding event.
‚ Direct indication of target binding
Direct detection of the template protein’s characteristic absorption bands in Raman [171] and
FTIR spectroscopy [172] offers the indication of the protein binding to the biomimetic recognition
element. For electroactive or intrinsically fluorescent proteins and certain enzymes, the direct electron
transfer [173] or fluorescence [174] and the assessment of enzymatic activity [59], respectively, offer a
selective means for the detection of the protein binding to the MIP. If the target protein does not possess
such properties, the rebinding can be selectively measured by applying a fluorescent or enzyme label
on the target [54,63]. Binding of the analyte to labeled aptamers—called molecular beacons—can
induce drastic conformational changes, which result in an enormous electrochemical signal or of
fluorescence [175].
‚ Fluorescence quenching of the MIP layer upon protein binding
Fluorescent particles can be incorporated in the MIP [176] or fluorophores can be coated onto
it [177] to make the polymer fluorescent. This fluorescence is then gradually quenched by binding of
the target protein in increasing concentrations. Similarly to the above electrochemical methods, low
protein concentrations are difficult to measure; therefore the limit of detection is generally in the low
micromolar range.
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‚ Changes in the MIP film permeability for an electro-active electrochemical probe
A frequently applied indirect method for the characterization of analyte binding to aptamers
or MIPs is based on measuring cyclic voltammetry (CV) or electrochemical impedance (EI) spectra.
It reflects the permeability of the recognition layer for a redox marker, e.g., ferrocyanide or ferrocene
carboxylic acid [69–72]. According to the simplified mechanism for MIPs in the absence of the target
protein, the empty binding sites permit the access of the redox marker to the underlying electrode
surface while the protein binding will decrease the permeability in a concentration dependent manner.
Problems may arise from the spontaneous adsorption of surface-active constituents of real samples
at the electrode surface, which will overlay the effect of the target binding to the aptamer or the MIP
cavities. A disadvantage of the method is that at low target concentrations minute decreases in the
current are to be detected in a large base current. Nevertheless, several papers describe MIP and
aptamer sensors for both low and high molecular weight targets with measuring ranges over several
orders of magnitude and with sub-nanomolar lower limit of detection [69,71].
6. Conclusions and Outlook
In spite of the shorter history of aptamers the spectrum of analytes and the number of publications
are comparable with that for MIPs. The highly reproducible production of “monoclonal” aptamers by
chemical synthesis is a clear advantage whilst the preparation of MIPs typically leads to polymers with
a distribution of different binding sites and differences between the batches of preparations. Progress
is expected from an enhanced functional monomer library combined either with a rational design
or with an empirical approach associated with high-throughput synthesis and detection platforms.
As compared with antibodies and aptamers, MIPs have been developed only for a restricted spectrum
of proteins and almost half of the published papers still use hemoglobin, serum albumins and avidin
as model templates. Detection of marker proteins for cardiovascular disease [67,71], cancer [46,178],
Alzheimer’s disease (AChE) [59] or virus infections are the prospective aims in the generation of MIPs.
In spite of several reports claiming applicability [71], MIPs need still substantial improvement to reach
the required sensitivity and to overcome disturbances caused by constituents of real samples.
As compared with antibodies or MIPs, the exchange rate of the aptamer-target complex is
considerably higher. Furthermore, the direct readout of the bound analyte is easier since the integration
of signal generating labels is well established. Both features make aptamers to potent candidates for
in vivo sensing.
Because their large-scale production is claimed to be cheaper than the preparation of antibodies,
MIPs are expected to be used as recognition elements in the decentralized medical diagnostics. For both
aptamers and MIPs, the measurement of groups of chemically similar substances (group effects) or
alternatively the indication of different analytes by only one recognition species would give additional
advantages in comparison with the biological pendants.
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